<DOC>
	<DOCNO>NCT00903526</DOCNO>
	<brief_summary>During past two decade , frequency invasive fungal infection increase dramatically hospitalise patient throughout world , Candida emerge one lead cause bloodstream infection ( BSIs ) . Risk-factors invasive candidiasis include improvement intensive care strategy ( i.e. , central venous catheter , mechanical ventilation , hyper-alimentation ) , prolong stay intensive care unit ( ICUs ) , development aggressive surgical technique , prolongation survival critically-ill patient . Two important factor , observe mainly cancer patient , colonization mucous membrane yeast , neutropenia , result increase use antibiotic anti-neoplastic agent , respectively . The crude mortality rate candidaemia high ( 38-75 % ) , attributable mortality estimate 25-38 % . During past 15 year , prevalence infection cause non-albicans Candida spp . increase exponentially , organisms account &gt; 50 % episode fungaemia various survey . The increase invasive fungal infection , associate high mortality rate , emergence antifungal resistance , drive search potent antifungal drug . The aims present study investigate prevalence epidemiology candidaemia determine antifungal susceptibility pattern Candida spp . isolate tertiary-care hospital Italy .</brief_summary>
	<brief_title>Prevalence Epidemiology Nosocomial Candidaemia Antifungal Susceptibility Patterns Italian Tertiary-Care Hospital</brief_title>
	<detailed_description />
	<mesh_term>Disease Susceptibility</mesh_term>
	<mesh_term>Candidemia</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<criteria>patient diagnose nosocomial candidaemia University Hospital Modena , Italy , January 1998 March 2008</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>fungal susceptibility</keyword>
</DOC>